TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) Director Laurence Charney sold 5,000 shares of the firm’s stock in a transaction dated Thursday, September 10th. The shares were sold at an average price of $54.96, for a total value of $274,800.00. Following the completion of the transaction, the director owned 168,640 shares in the company, […]

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) CEO Marshall Fordyce sold 18,500 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $35.12, for a total transaction of $649,720.00. Following the sale, the chief executive officer owned 235,244 shares of the company’s stock, […]

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) COO Mark Jacobson sold 10,000 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $208.65, for a total value of $2,086,500.00. Following the sale, the chief operating officer directly owned 10,000 shares in the company, […]